Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-12

FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Cosette Pharmaceuticals' original application for a generic Betamethasone Dipropionate topical product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

ORIG AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)